VIDD Staff Scientists & Physicians

Parul Agrawal, PhD

Parul Agrawal, PhD

Staff Scientist, Stamatatos Lab, Fred Hutch

Pre-clinical evaluation of vaccine candidates and adjuvants in animal models. Specifically, monitor the activation, survival and maturation of B cells that produce protective antibodies against HIV-1. Designing and characterizing HIV-1 immunogens.

Erica Andersen-Nissen, PhD

Erica Andersen-Nissen, PhD

Principal Staff Scientist, McElrath Lab, Fred Hutch
Principal Staff Scientist, HIV Vaccine Trials Network Leadership Center, Fred Hutch
Laboratory Director, Cape Town HVTN Immunology Laboratory

Research focus includes early innate immune responses to HIV vaccines on subsequent adaptive immune responses and systems biology analyses of how immune responses are shaped.

Michele Andrasik, PhD

Michele Andrasik, PhD

Director, Social & Behavioral Sciences and Community Engagement, HIV Vaccine Trials Network (HVTN) & COVID-19 Prevention Network (CoVPN)
Principal Staff Scientist, Immunology and Vaccine Development, Fred Hutch
Principal Staff Scientist, HIV Vaccine Trials Network Leadership and Operations Center, Fred Hutch
Affiliate Assistant Professor, Global Health, University of Washington
Affiliate Assistant Professor, Environmental and Occupational Health Sciences, University of Washington

Research focus includes sexual risk taking, victimization and alcohol/drug abuse among African-American women, HIV prevention for African American and African-born populations and health disparities.

Jessica Andriesen, PhD

Jessica Andriesen, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Fred Hutch

Clinical trial data management, Logistics, operations and study facilitation, Scientific communications, Host-pathogen interactions High-dimensional data analysis.

Rena D. Astronomo, PhD

Rena D. Astronomo, PhD

Senior Staff Scientist, McElrath Lab, Fred Hutch
Senior Staff Scientist, HIV Vaccine Trials Network Leadership Center, Fred Hutch

Research focus includes understanding mucosal immune responses to viral infections and vaccines, in particular, the contribution of passively administered and vaccine elicited antibodies to protection against HIV-1 transmission at the cervicovaginal mucosa.

Martine Aubert, PhD

Martine Aubert, PhD

Principal Staff Scientist, Jerome Lab, Fred Hutch

Research focus includes targeting latent viral genomes for mutagenesis and disruption of viral pathogenesis and infection using engineered homing endonucleases.

Leonard D'Amico, PhD

Leonard D'Amico, PhD

Staff Scientist, Immunology and Vaccine Development, Cancer Immunotherapy Trials Network (CITN), Vaccine and Infectious Disease Division, Fred Hutch

Immune profiling of cancer immunotherapy clinical trial subjects to further the understanding of therapy-driven patient immune responses in order to develop more effective cancer treatments.

Sayan Dasgupta, PhD

Sayan Dasgupta, PhD

Senior Staff Scientist, Immunology and Vaccine Development, Fred Hutch

Research focus includes supervised learning methods in infectious disease modeling, semiparametrics and Bayesian assessment of complex models.

Allan C. deCamp, PhD

Allan C. deCamp, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Fred Hutch

Correlates analysis, sieve analysis and antigenic mapping focusing on HIV-1 vaccines and immunology.

Dobromir Dimitrov, PhD

Dobromir Dimitrov, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
Senior Staff Scientist, Public Health Sciences Division, Fred Hutch
Affiliate Assistant Professor, Applied Mathematics, University of Washington

Research focus includes mathematical modeling of infectious diseases, evaluating impact of interventions for HIV prevention, mathematical biology (population dynamics, epidemic modeling) and dynamical systems (ODE, PDE, and impulsive systems).

One Bridget Dintwe, PhD

One Bridget Dintwe, PhD

Staff Scientist, Immunology and Vaccine Development, Fred Hutch
Research Officer, Cape Town HVTN Immunology Laboratory, HCRISA

Oversight for quality control of Good Clinical Lab Practice (GCLP)-compliant assays and is studying cellular immune responses to HIV vaccines for the Cape Town HVTN laboratory. Research involves interrogation of the phenotype and transcriptional profile of vaccine induced T cells in order to better understand these T cell responses.

Clara P. Domínguez Islas, PhD

Clara P. Domínguez Islas, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Fred Hutch

Design and analysis of trials for HIV prevention, methods for meta-analysis of clinical trials, Bayesian approaches for extrapolation of efficacy between populations.

Tracy Qi Dong, PhD

Tracy Qi Dong, PhD

Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Fred Hutch

Research focus includes statistical models of infectious diseases, analysis of observational and interventional studies, space-time modeling, and survey statistics.

Mike Duff, PhD

Mike Duff, PhD

Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Fred Hutch

B cell receptor sequence analysis

Paul Edlefsen, PhD

Paul Edlefsen, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
Affiliate Assistant Professor, Biostatistics, University of Washington

Statistical and computational methods for bioinformatics applications, statistical modeling for genome sequence analysis and statistical modeling frameworks. The interface between computer science, statistics, and molecular biology and such as development of new informatics methods in genomics and post-genomics.

Karsten Eichholz, PhD

Karsten Eichholz, PhD

Staff Scientist, Corey Lab, Infectious Disease Sciences, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes include development of cellular immunotherapies for HIV, chimeric antigen receptor design and in vitro testing, in vitro and in situ imaging of chimeric antigen receptor T cells.

Lynda Marie Emel, PhD

Lynda Marie Emel, PhD

Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
Associate Director, HPTN Statistical and Data Management Center, Vaccine and Infectious Disease Division, Fred Hutch

Clinical trial design and operations, good clinical data management practices (GCDMP), research regulations, behavioral research methodology, research ethics.

Andrew Fiore-Gartland, PhD

Andrew Fiore-Gartland, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Fred Hutch

Current studies include development of methods for T-cell based sieve analysis, quantification of vaccine induced T cell responses, systems biology of influenza and time-dependent correlates analysis of HIV efficacy trial.

Leigh Fisher, PhD

Leigh Fisher, PhD

Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

HVTN cross-protocol analyses

Lamar Fleming, BS

Lamar Fleming, BS

Staff Scientist, McElrath Lab, Immunoglogy and Vaccine Development Program
Staff Scientist, HVTN Laboratory Center, HIV Vaccine Trials Network

Research focus includes the development of new omics technologies in the lab including both bulk and single cell immune profiling looking at immune responses to HIV, SARS-CoV-2, and TB.

Steve Fling, PhD

Steve Fling, PhD

Senior Staff Scientist, Immunology and Vaccine Development, Cancer Immunotherapy Trials Network (CITN), Vaccine and Infectious Disease Division, Fred Hutch

Immune monitoring and correlative science analyses for early clinical trials in the area of cancer immunotherapy.

Briana D. Furch, MD, MPH

Briana D. Furch, MD, MPH

Staff Physician, Immunology and Vaccine Development, HIV Vaccine Trials Network (HVTN) Leadership and Operations Center, Vaccine and Infectious Disease Division, Fred Hutch
Clinical Trials Physician/Protocol Team Lead, HIV Vaccine Trials Network (HVTN) & CoVID 19 Prevention Network (CoVPN) Core

Research area includes immunology and vaccine design for development of vaccines, especially HIV-1 and SARS-CoV-2.

Elena E. Giorgi, PhD

Elena E. Giorgi, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Research area includes developing mathematical and statistical models to study viral evolution, immune correlates in infectious diseases (HIV, HCV, and SARS-CoV-2 in particular), and vaccine design. 

Jessica Graham, PhD

Jessica Graham, PhD

Senior Staff Scientist, Immunology and Vaccine Development, Vaccine and Infectious Disease Division, Fred Hutch

Roles of regulatory T cells in modulating anti-viral immunity, understanding the host immune response in anti-viral immunity and vaccine development.

Matthew D. Gray, PhD

Matthew D. Gray, PhD

Senior Staff Scientist, Immunology and Vaccine Development, Vaccine and Infectious Disease Division, Fred Hutch

Construction and evaluation of recombinant viral vectors for B cell engineering studies in mouse, human, and non-human primates. Molecular analyses of B cell responses to vaccination and tumor antigens. Binding and structural studies on neutralizing antibodies and their pathogen targets. Development of mono-, bi-, and tri-specific single-chain antibodies for B cell engineering studies and therapeutics. Optimization of Fc effector functions and circulation half-life for improved antibody therapeutics.

Brett Hanscom, PhD

Brett Hanscom, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Design and analytic methods for HIV prevention trials and measurement-error modeling and bias correction.

Joe (Jue) Hou, PhD

Joe (Jue) Hou, PhD

Senior Staff Scientist, Corey Lab, Infectious Disease Sciences, Vaccine and Infectious Disease Division, Fred Hutch

Utilizing computational immunology approaches to (1) reveal disease-induced specific immune responses and subsets in the temporal and spatial patterns; (2) explore the mechanism and disparity of vaccine protection; (3) discover the mechanism of individual variances in immune responses.

Tzu-Jung Huang, PhD

Tzu-Jung Huang, PhD

Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
Staff Scientist, Vaccine Immunology Statistical Center

Research focus includes high-dimensional testing, post-selection inference, statistical analysis and designs of platform trials, survival analysis, and vaccine efficacy evaluation.

Yunda Huang, PhD

Yunda Huang, PhD

Principal Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
Principal Staff Scientist, Public Health Sciences Division, Fred Hutch
Affiliate Associate Professor, Department of Global Health, University of Washington

Design and analysis of vaccine/monoclonal antibody clinical trials; immunological biomarker studies related to the prevention of infectious diseases; Pharmacokinetics modeling.

John Huddleston, PhD

John Huddleston, PhD

Staff Scientist, Bedford Lab, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Within the Bedford Lab, work includes independent research, software development, and educational outreach and mentorship. Research focus involves the evolution of seasonal influenza viruses, development of computational models to predict the composition of future influenza populations, and contribution of reports to the World Health Organization’s vaccine composition meetings. Also a core developer of Nextstrain’s real-time pathogen surveillance tools including the Augur bioinformatics toolkit and the SARS-CoV-2 genomic epidemiology workflow. This work builds on previous professional roles as a bioinformatics specialist and software developer and previous educational experiences including a master’s degrees in computer science and biology.

John Hural, PhD

John Hural, PhD

Principal Staff Scientist, Immunology and Vaccine Development, HIV Vaccine Trials Network (HVTN) Leadership Center and Leadership and Operations Center, Vaccine and Infectious Disease Division, Fred Hutch
Associate Director for Laboratory Operations, HIV Vaccine Trials Network (HVTN)

Immunologic endpoint determination for experimental vaccines (HIV, pneumococcus, malaria, TB, flu) and Logistics, operations, quality assurance, and assay validation for immunologic evaluation of vaccines in the clinical trial setting.

Nicholas K. Hurlburt, PhD

Nicholas K. Hurlburt, PhD

Staff Scientist, Pancera Lab, Immunology and Vaccine Development, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes leveraging structural biology techniques like X-ray crystallography and cryoEM to understand the molecular-level interactions between pathogens and the host immune system, with a focus on developing vaccines and antibody-based therapeutics.

Andrew Johnson, PhD, BS

Andrew Johnson, PhD, BS

Staff Scientist, Kublin Lab, Immunology and Vaccine Development, HIV Vaccine Trials Network (HVTN) Leadership and Operations Center, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes understanding how the microbiome regulates our immune response, especially in the context of vaccination. In particular, studying how microbial exposure shapes immune development and the response to vaccination.

Daniel Jones, PhD

Daniel Jones, PhD

Staff Scientist, Newell Lab, Immunology and Vaccine Development, Vaccine and Infectious Disease Division, Fred Hutch

Developing statistical methods for the analysis of spatial transcriptomics and spatial genomics data.

Michal Juraska, PhD

Michal Juraska, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Design and analysis of vaccine efficacy trials, genotype-specific vaccine efficacy-based sieve analysis, immune correlates of vaccine protection, analysis of vaccine-induced immune response durability and survival analysis.

Latha Kallur Siddaramaiah, PhD

Latha Kallur Siddaramaiah, PhD

Staff Scientist, Stamatatos Lab, Immunology and Vaccine Development, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes vaccine manufacturing, characterization and immunological evaluation of drug substance and drug product, and vaccine adjuvant studies.

Angela Shaulov Kask, PhD

Angela Shaulov Kask, PhD

Staff Scientist, Immunology and Vaccine Development, Cancer Immunotherapy Trials Network (CITN), Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes cancer immunology/translational immunology/viral immunology/cellular immunology, immune monitoring and correlative science data analyses in cancer immunotherapy clinical trials.

Maria P. Lemos, PhD, MPH

Maria P. Lemos, PhD, MPH

Staff Scientist, Immunology and Vaccine Development, HIV Vaccine Trials Network (HVTN) Leadership Center, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes studying the barrier and immune mechanisms that contribute to protection after circumcision, vaccine or passive immunizations at mucosal sites of encounter with HIV.

Shuying (Sue) Li, PhD

Shuying (Sue) Li, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
Senior Staff Scientist, Public Health Sciences Division, Fred Hutch

Development of genetic statistical methodologies, including phylogenetic tree reconstruction from genetic sequences.

Xiaohong Li, PhD

Xiaohong Li, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Application of statistical and machine learning methods in molecular genetics and immunology of infectious diseases. Study relationship of human host genetics, SARS-Cov-2 clinical symptoms and immunogenicity reaction. Longitudinal immunogenicity reactions after SARS-Cov-2 infection. SARS-Cov-2 and HIV virus evolutionary dynamics over time and clonal dynamics interactions in human hosts and HIV infected population. Population dynamics of infectious disease transmission and interactions between hosts and pathogen from molecular genetics point of view. Quantitative evaluation of early detection of cancer and infectious diseases.

Troy Martin, MD, MPH

Troy Martin, MD, MPH

Staff Scientist, Immunology and Vaccine Development, HIV Vaccine Trials Network (HVTN) Leadership and Operations Center, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes the development of HIV vaccines for adults and children. Part of the core leadership team on network strategic planning and implementation, as the HVTN Chief of Staff. Primary research focus is in the HVTN’s phase 1 experimental medicine program for induction of broadly neutralizing antibodies against sites of vulnerability on the HIV envelope protein.

Laura Matrajt, PhD

Laura Matrajt, PhD

Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Research lies at the interface of mathematics, computer science, biology, and public health policy. Utilizing and developing quantitative tools including dynamical systems, differential equations, stochastic processes, operations research and optimization to understand complex biological processes.

Bryan Mayer, PhD

Bryan Mayer, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes analysis of immune responses to vaccine candidates, study design for challenge studies, statistical methods for biological assays, mathematical models of viral load kinetics, and pharmacokinetic/pharmacodynamic modeling.

Samuel Minot, PhD

Samuel Minot, PhD

Staff Scientist, Fredricks Lab, Infectious Disease Sciences, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes the role of the microbiome in human health and disease.

Zoe Moodie, PhD

Zoe Moodie, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
Senior Staff Scientist, Public Health Sciences Division, Fred Hutch

Research focus includes design and analysis of vaccine clinical trials, immune correlates of risk and protection, statistical training and capacity building.

Mia Moore, PhD

Mia Moore, PhD

Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Mathematical modeling of HIV and CoVID epidemiology

Carmen Paez, MD, MBA

Carmen Paez, MD, MBA

Staff Physician, Immunology and Vaccine Development, HIV Vaccine Trials Network (HVTN) Leadership and Operations Center, Vaccine and Infectious Disease Division, Fred Hutch
Clinical Trials Physician/Protocol Team Leader, HIV Vaccine Trials Network (HVTN)

HIV vaccine development and clinical trial design. Monoclonal antibodies clinical trial design for HIV prevention. Mucosal sampling in HIV prevention clinical trials. Leadership in developing and implementing clinical trials for HIV vaccines and monoclonal antibodies. Safety monitoring oversight for clinical trials.

Rachael Parks, PhD

Rachael Parks, PhD

Staff Scientist, Immunology and Vaccine Development, Vaccine and Infectious Disease Division, Fred Hutch

Immune profiling of antigen-specific B cell responses to vaccines and infection.

Sivasankaran M. Ponnan, PhD

Sivasankaran M. Ponnan, PhD

Staff Scientist, Immunology and Vaccine Development, Vaccine and Infectious Disease Division, Fred Hutch
Staff Scientist (T-cell Immunologist), HIV Vaccine Trials Network (HVTN)

Oversight of the Good Clinical Lab Practice (GCLP) - compliant assays and studies cellular immune responses to candidate vaccines at the HVTN End Point GCLP laboratory. Execute assays supporting the HVTN and CoVPN clinical trials and assist with clinical trial operations. Research interests include single-cell genomics and high parameter flow cytometry to examine vaccine-induced T cells' proliferative capabilities, phenotypic traits, and migration potential.

Nirasha Ramchurren, PhD

Nirasha Ramchurren, PhD

Staff Scientist, Immunology and Vaccine Development, Cancer Immunotherapy Trials Network (CITN), Vaccine and Infectious Disease Division, Fred Hutch

Identifying correlates of immune response in immunotherapy trials

April Kaur Randhawa, PhD

April Kaur Randhawa, PhD

Senior Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
Associate Director, Laboratory & Data Science, HIV Vaccine Trials Network (HVTN) & COVID-19 Prevention Network (CoVPN)

Infectious disease biologist researching prevention strategies for globally important pathogens such as HIV, tuberculosis, and COVID-19.

Daniel B. Reeves, PhD

Daniel B. Reeves, PhD

Staff Scientist, Schiffer Group, Infectious Disease Sciences, Vaccine and Infectious Disease Division, Fred Hutch

Creates mathematical models of viral and immune system dynamics and evolution. Uses theoretical and computational methods to better understand host-pathogen interplay and inform the development of preventative and curative interventions.

Mingchao Shen, PhD

Mingchao Shen, PhD

Senior Staff Scientist, Immunology and Vaccine Development, HIV Vaccine Trials Network (HVTN) Leadership Center, Vaccine and Infectious Disease Division, Fred Hutch
Associate Director Project Management, HVTN Laboratory Center, HIV Vaccine Trials Network (HVTN)

Research focus includes preclinical animal models for vaccines and adjuvants testing, vaccine product development and clinical trial design, vaccine adjuvants, formulations and innate immune responses, immunological evaluation of vaccines and project management for collaborative research projects.

Anton M. Sholukh, PhD

Anton M. Sholukh, PhD

Senior Staff Scientist, Infectious Disease Sciences, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes the analysis of humoral immune response to HSV-2 and its vaccine candidates and understanding the role of tissue B cells in HSV-2 infection.

Timothy Skalland, PhD

Timothy Skalland, PhD

Staff Scientist, Biostatistics, Bioinformatics & Epidemiology, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes the design and analysis of group-sequential and complex clinical trials, specifically as pertaining to HIV prevention trials.

Sujatha Srinivasan, PhD

Sujatha Srinivasan, PhD

Principal Staff Scientist, Fredricks Lab, Infectious Disease Sciences, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes ecology of human microbial communities, impact of bacterial interactions on health and disease, molecular diagnosis of bacterial pathogens and bacterial adaptive responses.

Daniel Stone, PhD

Daniel Stone, PhD

Senior Staff Scientist, Jerome Lab, Infectious Disease Sciences, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes development of DNA editing enzymes that target the genomes of viruses that undergo latent infections and viral vectors for gene delivery to sites of latent viral infection.

Jean de Dieu Tapsoba, PhD

Jean de Dieu Tapsoba, PhD

Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes the development and application of statistical methods to account for measurement error, missing data and selection bias in regression analyses of cross-sectional, longitudinal or survival data from clinical trials and observational studies in cancer and HIV/AIDS prevention research areas.

Manuel V. Villaran, MD, MS, MPH

Manuel V. Villaran, MD, MS, MPH

Clinical Trials Physician/Protocol Team Leader, HIV Vaccine Trials Network (HVTN), Vaccine and Infectious Disease Division, Fred Hutch

HIV and COVID-19 vaccine development and trial design

Emily Voldal, PhD

Emily Voldal, PhD

Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes the design and analysis of HIV prevention trials, and statistical methods for cluster-randomized trials.

Stephaun Elite Wallace, PhD, MS

Stephaun Elite Wallace, PhD, MS

Principal Staff Scientist, Immunology and Vaccine Development, HIV Vaccine Trials Network (HVTN) Leadership and Operations Center, Vaccine and Infectious Disease Division, Fred Hutch
Director of External Relations, HIV Vaccine Trials Network, Fred Hutch
Clinical Professor, Dept. of Global Health, University of Washington

Research commitment, inquiry, and interests are situated at the intersection of public health and social justice to further understand and mitigate the impacts of structural and social factors like stigma, racism, sexism, homophobia/transphobia, historical trauma, and education and income inequities on population-level health. Particularly interested in the health and wellbeing of Black and LGBTQ populations.

Marius Walter, PhD

Marius Walter, PhD

Staff Scientist, Jerome Lab, Infectious Disease Sciences, Vaccine and Infectious Disease Division, Fred Hutch

Development of viral vectors to cure latent infections with herpesviruses

Martha Zepeda Rivera, PhD

Martha Zepeda Rivera, PhD

Staff Scientist, Johnston Lab, Vaccine and Infectious Disease Division, Fred Hutch

Research focus includes characterizing tumor-associated microbial communities and analyzing the genomic diversity across isolates to identify disease-relevant genes/strains.

Yifan Zhu, PhD

Yifan Zhu, PhD

Staff Scientist, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch

Statistical methods in HIV/AIDS research and monitoring and analyzing drug adherence patterns. Transmission models for infectious disease epidemiology.